Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor 2B (5-HT2B) or serotonin receptor 2B is a protein encoded by the HTR2B gene. It plays a role in the regulation of behavior, including impulsive behavior. ... Read More
-
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... the recently published report '5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2022'; 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) pipeline Target constitutes close to 16 molecules. Out of ... Read More
-
Biologics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... registering a CAGR of 9.22% during the forecast period, 2022-2027. With the growing COVID-19 burden, there has been a huge demand for biologics during the pandemic, which may drive the market growth. For instance, in ... Read More
-
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... or GRM1) - Metabotropic glutamate receptor 1 (mGluR1) is a protein encoded by GRM1. It activates a phosphatidylinositol-calcium second messenger system. It participates in the central action of glutamate in the CNS, such as long-term ... Read More
-
Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Glutamate Receptor 7 - Drugs In Development, 2022'; Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and ... Read More
-
Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... constitutes close to 5 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the universities/institutes. The latest report Neuronal Acetylcholine Receptor Subunit Alpha 4 - Drugs In Development, 2022, outlays ... Read More
-
Gastric and Gastroesophageal Junction Adenocarcinoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
... fifth most common form of cancer: The standard of care in the first-line for both HER2-positive and -negative patients is now changing following the approvals of Opdivo in combination with chemotherapy for HER2-negative patients across ... Read More
-
Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... of Neuroendocrine tumors will reach to 689,000 cases across the 16 countries covered in GlobalData’s epidemiology forecast. There are eight leading marketed drugs for the treatment of Neuroendocrine tumors. Pfizer, Novartis, and Hutchison are key ... Read More
-
Healthcare Contract Research Outsourcing Market, By Service Type (Safety Syringes (Clinical Trials (Drug Discovery, Preclinical, Phase I, Phase II, Phase III, Phase IV)), Regulatory services, Medical writing, Clinical data management, Others), By End User
... Clinical Trial Laboratories, AMCs), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Healthcare Contract Research Outsourcing is conducted by ... Read More
-
Alport Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... of Alport syndrome will reach to 359,000 cases across the 16 countries covered in GlobalData’s epidemiology forecast. There are no approved marketed products for the treatment of Alport syndrome. R&D activity in Alport syndrome is ... Read More
-
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Clinical trials scenario. This report provides ... Read More
-
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical trials scenario. This report provides ... Read More
-
Consumer Asset Tracking Solutions 1st Edition
... market in Europe and North America. This strategic research report provides you with 170 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions. The key ... Read More
-
Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Pneumonia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pneumonia. Report includes ... Read More
-
Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Clostridioides difficile Infections (Clostridium difficile Associated Disease) ... Read More
-
Pseudomonas aeruginosa Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Pseudomonas aeruginosa Infections Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Somatropin Market, By Dosage Form (Powder and Solvent), By Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, and Others), By Distribution Channel
... Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 The increasing prevalence of growth hormone ... Read More
-
Chronic Urticaria Or Hives Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Chronic Urticaria Or Hives Clinical trials scenario. This report provides top line data ... Read More
-
Oral Mucositis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Oral Mucositis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Critical Limb Ischemia Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Recurrent Glioblastoma Multiforme (GBM) Clinical trials scenario. This report provides top line data ... Read More
-
Clinical Trial Biorepository & Archiving Solutions Market
... and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are ... Read More
-
Coronavirus Vaccine Market, by Vaccine Type (Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed Vaccines, RNA Vaccine, and DNA Vaccine) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
... Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. COVID-19 is a viral infection caused ... Read More
-
Clinical Trials - Where are we Headed with COVID-19 Trials?
... this report is to provide insight into the overall clinical trial landscape for COVID-19 clinical trials, trials using vaccines versus therapeutics, trials impacted by COVID-19, and testing/vaccination data. Scope The clinical trials data used for ... Read More
-
Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Glioblastoma Multiforme (GBM) Clinical trials scenario. This report provides top line data relating to the ... Read More
Research Assistance
